Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Artificial Intelligence (AI) In Omics Studies Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The market for artificial intelligence (AI) in omics studies has expanded significantly in recent years. This market is projected to expand from $1.23 billion in 2025 to $1.67 billion in 2026, achieving a compound annual growth rate (CAGR) of 35.4%. Factors contributing to this historical growth include the advancement of next-generation sequencing technologies, the proliferation of bioinformatics tools, the growing volume of biological big data, the initial implementation of machine learning in genomics, and increased investment in life science research.
The artificial intelligence (AI) in omics studies market size is anticipated to undergo significant growth in the upcoming years, projected to reach $5.55 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 35.0%. This expansion during the forecast period is driven by factors such as the increasing demand for precision medicine, advancements in deep learning algorithms, rising adoption of AI in drug discovery, the expansion of cloud-based omics platforms, and a growing focus on personalized healthcare. Key trends during this period will include AI-powered multi-omics data integration, machine learning-based genomic interpretation, AI-driven protein structure prediction, automated omics data analytics platforms, and predictive biomarker discovery.
Download A Free Sample Report For Comprehensive Market Insights:
Artificial Intelligence (AI) In Omics Studies Market Growth Momentum: Which Factors Are Influencing Demand?
The increasing need for personalized medicine is anticipated to drive the advancement of artificial intelligence within the omics studies market. Personalized medicine is defined as customizing medical care to align with the unique characteristics of each patient. It works by optimizing the effectiveness of therapies and minimizing negative side effects through the consideration of genetic, environmental, and lifestyle aspects. The expanding adoption of personalized medicine can be attributed to innovations in genomic medicine, enhanced diagnostic tools, and data-driven healthcare methods. AI in omics studies significantly boosts personalized medicine by facilitating deeper understanding into the molecular origins of diseases, refining the accuracy of treatments, and ultimately resulting in improved patient outcomes. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, announced that the FDA had sanctioned 16 novel personalized treatments for patients with rare diseases in 2023, representing a substantial increase compared to the 6 approvals in 2022. Consequently, the rising demand for personalized medicine is a primary factor fueling the expansion of artificial intelligence in omics studies.
Artificial Intelligence (AI) In Omics Studies Market Segment Breakdown: Which Categories Generate The Most Revenue?
The artificial intelligence (AI) in omics studies market covered in this report is segmented –
1) By Offering: Software, Services
2) By Technology Platform: Sequencing, Epigenomics, Proteomics, Metabolomics, Other Technologies
3) By Application: Oncology, Infectious Diseases, Neurology, Cardiovascular Diseases, Immunology, Other Applications
4) By End-User: Academic And Research Institutes, Biopharmaceutical Company, Other End-Users
Subsegments:
1) By Software: AI-Powered Data Analytics Software, Omics Data Integration Software, Machine Learning Platforms for Genomics, AI-Based Protein Structure Prediction Software, AI-Based Drug Discovery Software, AI for Metabolomics Analysis Tools, AI-Driven Genome Sequencing Software, Bioinformatics Software for Multi-Omics Data
2) By Services: AI-Based Data Analysis Services, Consulting Services for AI in Omics, AI Model Development and Customization Services, Omics Data Management and Interpretation Services, AI-Driven Drug Discovery and Development Services, Cloud-Based Omics Data Storage and Processing Services, AI-Based Omics Training and Support Services
#Artificial Intelligence (AI) In Omics Studies Market Trends Influencing Long-Term Demand
Leading companies within the artificial intelligence in omics studies market are dedicated to creating sophisticated solutions, specifically cloud-based platforms that leverage data federation principles to enhance data sharing and cooperative efforts among various research institutions. These platforms enable the smooth integration and analysis of extensive omics data originating from multiple sources, all while upholding data privacy and security standards. Such cloud-based systems consolidate diverse omics data types, including genomics, proteomics, and metabolomics, employing machine learning algorithms to process this data and extract valuable insights. For instance, in September 2023, DNAstack, a Canada-based biotechnology company, introduced Omics AI, a pioneering software suite crafted to accelerate omics research. The distinct capabilities of Omics AI encompass its capacity to manage substantial datasets, deliver real-time analytics, and foster worldwide collaboration among researchers. This innovation significantly boosts the efficiency of omics studies, although it concurrently highlights concerns regarding data privacy and the necessity for robust cybersecurity measures to protect sensitive genetic information.
Artificial Intelligence (AI) In Omics Studies Market Key Players And Strategic Industry Positioning
Major companies operating in the artificial intelligence (AI) in omics studies market are Amazon.com Inc. , Hitachi Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Siemens Healthineers AG, General Electric Company, Agilent Technologies Inc., Koninklijke Philips N.V., Dassault Systemes SA, Illumina Inc., Fujifilm Holdings Corporation, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Canon Medical Systems Corporation, Bruker Corporation, Qiagen N.V., BGI Genomics Co Ltd., Takara Bio Inc., Elekta AB
Access The Complete Artificial Intelligence (AI) In Omics Studies Market Report:
Artificial Intelligence (AI) In Omics Studies Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the artificial intelligence in omics studies market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in omics studies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.